These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35975336)

  • 1. Prognostic value of the modified advanced lung cancer inflammation index in overweight or obese patients with lung cancer: Results from a multicenter study.
    Xie H; Ruan G; Wei L; Zhang Q; Ge Y; Song M; Zhang X; Lin S; Liu X; Li X; Zhang K; Yang M; Tang M; Song C; Shi H
    JPEN J Parenter Enteral Nutr; 2023 Jan; 47(1):120-129. PubMed ID: 35975336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia.
    Xie HL; Ruan GT; Wei L; Zhang Q; Ge YZ; Song MM; Zhang X; Lin SQ; Liu XY; Zhang XW; Li XR; Zhang KP; Hu CL; Yang M; Tang M; Song CH; Cong MH; Weng M; Li ZN; Li W; Wang KH; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):879-890. PubMed ID: 36872512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI.
    Kim EY; Kim N; Kim YS; Seo JY; Park I; Ahn HK; Jeong YM; Kim JH
    PLoS One; 2016; 11(10):e0164056. PubMed ID: 27706243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index in Patients With Renal Cell Carcinoma Undergoing Laparoscopic Nephrectomy: A Multi-Institutional, Propensity Score Matching Cohort Study.
    Mao W; Wang K; Wu Y; Ni J; Zhang H; Wang Y; Wu Z; Liu R; Geng J; Chen S; Chen M
    Front Nutr; 2021; 8():781647. PubMed ID: 35127784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.
    Tong YS; Tan J; Zhou XL; Song YQ; Song YJ
    J Transl Med; 2017 Oct; 15(1):221. PubMed ID: 29089030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of preoperative evaluation of modified advanced lung cancer inflammation index for patients with resectable non-small cell lung cancer.
    Sato S; Sezaki R; Shinohara H
    Gen Thorac Cardiovasc Surg; 2024 Jan; ():. PubMed ID: 38246904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy.
    Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G
    Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer.
    Song M; Zhang Q; Song C; Liu T; Zhang X; Ruan G; Tang M; Xie H; Zhang H; Ge Y; Li X; Zhang K; Yang M; Li Q; Liu X; Lin S; Xu Y; Xu H; Wang K; Li W; Shi H
    J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2504-2514. PubMed ID: 35833264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
    Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
    Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of the advanced lung cancer inflammation index (ALI) for patients with neuroblastoma.
    Qi C; Zhou Y; Hu Z; Niu H; Yue F; An H; Chen Z; Wang P; Wang L; Duan G
    J Int Med Res; 2022 Jun; 50(6):3000605221109382. PubMed ID: 35770522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutrition-inflammation marker enhances prognostic value to ECOG performance status in overweight or obese patients with cancer.
    Zhang X; Zhang Q; Tang M; Zhang KP; Zhang XW; Song MM; Ruan GT; Sun Q; Li W; Xu HX; Cong MH; Deng L; Shi HP
    JPEN J Parenter Enteral Nutr; 2023 Jan; 47(1):109-119. PubMed ID: 35589385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non-small cell lung cancer.
    Xie H; Ruan G; Wei L; Deng L; Zhang Q; Ge Y; Song M; Zhang X; Lin S; Liu X; Yang M; Song C; Zhang X; Shi H
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):869-878. PubMed ID: 36852672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator.
    Chen L; Chen Y; Zhang L; Xue Y; Zhang S; Li X; Song H
    Pathol Oncol Res; 2021; 27():1609811. PubMed ID: 34712105
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic immune-inflammation index changes predict outcome in stage III non-small-cell lung cancer patients treated with concurrent chemoradiotherapy.
    Huang T; Zhang H; Zhao Y; Li Y; Wang G; Zhang Y; Guo D; Ji S; Sun Z
    Future Oncol; 2021 Jun; 17(17):2141-2149. PubMed ID: 33635094
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prognostic value of pretreatment neutrophil-to-lymphocyte ratio (NLR) in locally advanced non-small cell lung cancer patients treated with thoracic radiation].
    Dong X; Zhou ZM; Bi N; Wang JB; Ran JT; Hui ZG; Liang J; Feng QF; Chen DF; Xiao ZF; Lyu JM; Wang XZ; Wang X; Zhang T; Deng L; Wang WQ; Wang LH
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):446-451. PubMed ID: 29936771
    [No Abstract]   [Full Text] [Related]  

  • 18. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
    Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
    BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between Prognostic Nutritional Index and Mortality in Overweight or Obese Patients with Cancer: A Multicenter Observational Study.
    Zhang X; Li JH; Zhang Q; Li QQ; Zhang KP; Tang M; Ge YZ; Li W; Xu HX; Guo ZQ; Shi HP
    J Inflamm Res; 2021; 14():3921-3932. PubMed ID: 34421305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.
    Demirelli B; Babacan NA; Ercelep Ö; Öztürk MA; Kaya S; Tanrıkulu E; Khalil S; Hasanov R; Alan Ö; Telli TA; Koca S; Arıbal ME; Kuzan B; Dane F; Yumuk PF
    Nutr Cancer; 2021; 73(2):230-238. PubMed ID: 32270713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.